Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapy

Similar Items

• Prolonged treatment-free remission in chronic myeloid leukemia patients with previous BCR-ABL1 kinase domain mutations
  od: Claudiani, Simone, i dr.
  Izdano: (2020)
• Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemias
  od: Nicolini, Franck Emmanuel, i dr.
  Izdano: (2011)
• E14a2 BCR-ABL1 transcript is associated with a higher rate of treatment-free remission in individuals with chronic myeloid leukemia after stopping tyrosine kinase inhibitor therapy
  od: Claudiani, Simone, i dr.
  Izdano: (2017)
• Is the BCR-ABL/GUSB transcript level at diagnosis an early predictive marker for chronic myeloid leukemia patients treated with imatinib?
  od: Bonecker, Simone, i dr.
  Izdano: (2015)
• Chronic Myeloid Leukemia with an e6a2 BCR-ABL1 Fusion Transcript: Cooperating Mutations at Blast Crisis and Molecular Monitoring
  od: Mireille Crampe, i dr.
  Izdano: (2017-01-01)